AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Pharmaceutical Companies

673.808

-2.556-0.38%

Number of Gainers:10

Number of Losers:14

Number of Flat:19

PE:- -

High:685.239

Open:680.163

Low:669.907

Close:676.364

Volume:63.38M

Turnover:92.19M

Market Cap:96.84B

Float Cap:93.72B

Loading ...

Mayne Pharma Group Settles Patent Litigation With Sun Pharmaceutical Industries

MT Newswires Live

Paradigm Biopharmaceuticals Says Board Initiates Voluntary Administration

Mayne Pharma Group - Settlement Does not Include Financial Payment or Upfront Monetary Consideration

THOMSON REUTERS

Mayne Pharma Group - Generic Imvexxy Agreed Market Entry Date Set for 21 October 2032

THOMSON REUTERS

Paradigm Biopharmaceuticals Ltd-Board Initiates Voluntary Administration

THOMSON REUTERS

Paradigm Biopharmaceuticals - Board Intends to Develop Proposal for Deed of Company Arrangement

THOMSON REUTERS

Paradigm Biopharmaceuticals - Clinical Review and Restructuring Process Expected to Take at Least Eight Weeks

THOMSON REUTERS

Paradigm Biopharmaceuticals - Securities Remain Suspended from Trading on ASX During Administration

THOMSON REUTERS

4DMedical And 2 Other Australian Growth Stocks To Own

Simply Wall St.

CSL Seqirus Expands U.S. Availability of Influenza Vaccine Following Successful Completion of the 2026/27 Manufacturing Campaign

THOMSON REUTERS

CSL Partners With Amazon Web Services

MT Newswires Live

CSL Ltd and AWS Collaborate to Advance Biopharmaceutical Research and Development

Neuren Says US Patent Allowance Could Extend Trofinetide Protection to 2041

MT Newswires Live

CSL Partners with AWS to Apply AI, Cloud Tools in Biopharma R&D

CSL Ltd - Collaboration with Amazon Web Services

THOMSON REUTERS

In Clinical Development, CSL Working with AWS to Reduce Manual Effort in Areas Including Protocol Authoring, Others

THOMSON REUTERS

CSL Ltd - CSL and AWS Collaborate to Advance Biopharmaceutical R&D

THOMSON REUTERS

CSL Ltd - Collaboration with AWS to Apply Artificial Intelligence and Cloud Technologies to Support Co's Research & Clinical Development

THOMSON REUTERS

Mayne Pharma to Pay $650,000 to Settle US Generic Drug Claims

MT Newswires Live

Mayne Pharma Group - Settlement Made Without Admission of Liability or Wrongdoing by Mayne Pharma

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/BK7508/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BK7508","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK7508\",,,,,undefined,":{"symbol":"BK7508","market":"AU","secType":"PLATE","nameCN":"Pharmaceutical Companies","latestPrice":673.8078,"timestamp":1791435599598,"preClose":676.3637,"halted":0,"volume":63375929,"delay":0,"changeRate":-0.003779,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Closed","change":-2.555908,"latestTime":"10-08 16:00:00 AEDT","open":680.1626,"high":685.2389,"low":669.9068,"amount":92191055,"amplitude":0.022668,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1791500400000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1791414000000,1791435600000]],"turnoverRate":0.00252,"increases":9,"decrements":13,"flats":20,"marketCap":96835706888,"floatMarketCap":93723403428.875},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK7508\",,,,,undefined,":{"symbol":"BK7508","high":685.2389,"amplitude":0.022668,"preClose":676.3637,"low":669.9068,"latestPrice":673.8078,"volume":63375929,"delay":0,"open":680.1626,"prevYearClose":644.3692,"prevWeekClose":654.21,"prevMonthClose":689.549,"prevQuarterClose":689.549,"fiveDayClose":666.631,"twentyDayClose":646.103,"sixtyDayClose":495.646,"secType":"PLATE","market":"AU","turnoverRate":0.00252,"marketCap":96835706888,"floatMarketCap":93723403428.875,"timestamp":1791435599598,"nameCN":"Pharmaceutical Companies"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK7508\",,,,undefined,":{"bkCode":"BK7508","up":10,"down":14,"flat":19},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK7508\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2671226535","title":"Mayne Pharma Group Settles Patent Litigation With Sun Pharmaceutical Industries","url":"https://stock-news.laohu8.com/highlight/detail?id=2671226535","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671226535?lang=en_us&edition=fundamental","pubTime":"2026-09-30 08:55","pubTimestamp":1790729716,"startTime":"0","endTime":"0","summary":"Mayne Pharma Group  settled Paragraph IV patent litigation with Sun Pharmaceutical Industries concerning Imvexxy, an estradiol vaginal insert used to treat moderate to severe menopause-related dyspareunia, including disputes over patents listed for the drug in the US Food and Drug Administration's Orange Book, according to a Wednesday Australian bourse filing.Sun Pharma's generic version of the treatment may enter the US market on Oct. 21, 2032, or earlier under certain circumstances, subject to court approval, with no financial payment or upfront consideration between the parties, the filing said.The company said the settlement reinforces the validity and enforceability of its patent portfolio covering the product, with the final patent set to expire in February 2034, the filing added.The specialty pharmaceutical company's shares gained about 1% in recent Wednesday trade.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["MYX.AU","BK7508","BK7096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671223116","title":"Paradigm Biopharmaceuticals Says Board Initiates Voluntary Administration","url":"https://stock-news.laohu8.com/highlight/detail?id=2671223116","media":"Reuters","labels":["executive","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671223116?lang=en_us&edition=fundamental","pubTime":"2026-09-30 07:52","pubTimestamp":1790725977,"startTime":"0","endTime":"0","summary":"BRIEF-Paradigm Biopharmaceuticals Says Board Initiates Voluntary AdministrationSept 30 (Reuters)-Paradigm Biopharmaceuticals LtdPAR.AX:INITIATES VOLUNTARY ADMINISTRATION PROCESSBOARD INTENDS TO DEVELO","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nTUE6WRYYG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"Paradigm Biopharmaceuticals Says Board Initiates Voluntary Administration","news_tag":"executive,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","BK7067","PAR.AU"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2671522319","title":"Mayne Pharma Group - Settlement Does not Include Financial Payment or Upfront Monetary Consideration","url":"https://stock-news.laohu8.com/highlight/detail?id=2671522319","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671522319?lang=en_us&edition=fundamental","pubTime":"2026-09-30 07:49","pubTimestamp":1790725788,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nFWN45L1TF:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","BK7096","MYX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671223194","title":"Mayne Pharma Group - Generic Imvexxy Agreed Market Entry Date Set for 21 October 2032","url":"https://stock-news.laohu8.com/highlight/detail?id=2671223194","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671223194?lang=en_us&edition=fundamental","pubTime":"2026-09-30 07:49","pubTimestamp":1790725788,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nFWN45L1TF:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MYX.AU","BK7096","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671997223","title":"Paradigm Biopharmaceuticals Ltd-Board Initiates Voluntary Administration","url":"https://stock-news.laohu8.com/highlight/detail?id=2671997223","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671997223?lang=en_us&edition=fundamental","pubTime":"2026-09-30 07:47","pubTimestamp":1790725675,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nTUE6WRYYG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","BK7067","PAR.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671722391","title":"Paradigm Biopharmaceuticals - Board Intends to Develop Proposal for Deed of Company Arrangement","url":"https://stock-news.laohu8.com/highlight/detail?id=2671722391","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671722391?lang=en_us&edition=fundamental","pubTime":"2026-09-30 07:47","pubTimestamp":1790725675,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nTUE6WRYYG:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PAR.AU","BK7067","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671322394","title":"Paradigm Biopharmaceuticals - Clinical Review and Restructuring Process Expected to Take at Least Eight Weeks","url":"https://stock-news.laohu8.com/highlight/detail?id=2671322394","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671322394?lang=en_us&edition=fundamental","pubTime":"2026-09-30 07:47","pubTimestamp":1790725675,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nTUE6WRYYG:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","PAR.AU","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671223910","title":"Paradigm Biopharmaceuticals - Securities Remain Suspended from Trading on ASX During Administration","url":"https://stock-news.laohu8.com/highlight/detail?id=2671223910","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671223910?lang=en_us&edition=fundamental","pubTime":"2026-09-30 07:47","pubTimestamp":1790725675,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nTUE6WRYYG:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","BK7067","PAR.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671277550","title":"4DMedical And 2 Other Australian Growth Stocks To Own","url":"https://stock-news.laohu8.com/highlight/detail?id=2671277550","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671277550?lang=en_us&edition=fundamental","pubTime":"2026-09-30 07:21","pubTimestamp":1790724093,"startTime":"0","endTime":"0","summary":"Australia’s interest rate now sits at a 15 year high of 4.6%, which makes dependable earnings growth harder to find and more valuable when you do. Higher borrowing costs punish weak balance sheets, yet stronger businesses with solid finances and clear profit expansion stories can still build wealth. This article highlights three Australian high growth potential stocks from our healthy growth screen that fit that profile.\nThe three stocks covered below are a small sample, with the full healthy...","market":"sg","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/9551730-choice1-card/1788960340613","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/9551730-choice1-card/1788960340613"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-4dx/4dmedical-shares/news/4dmedical-and-2-other-australian-growth-stocks-to-own","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-4dx/4dmedical-shares/news/4dmedical-and-2-other-australian-growth-stocks-to-own","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["IMLC.AU","BK7094","E200.AU","STW.AU","GXDW","XAO.AU","BBOZ.AU","4DX.AU","FEBU","IOZ.AU","BK7508","NEU.AU","BK7043","JOYT","GIVE.AU","VAP.AU","QRE.AU","XKO.AU","PMDE","GEAR.AU","QFN.AU","BK7096","VGFPF","BK7503","XJO.AU","ZYAU.AU","IISV.AU","RGLO","VOTE","MP1.AU","OZF.AU","EIGA.AU","OZR.AU","IIGF.AU","DACE.AU","BEAR.AU","DECU","SLF.AU","VAS.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671179142","title":"CSL Seqirus Expands U.S. Availability of Influenza Vaccine Following Successful Completion of the 2026/27 Manufacturing Campaign","url":"https://stock-news.laohu8.com/highlight/detail?id=2671179142","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671179142?lang=en_us&edition=fundamental","pubTime":"2026-09-29 21:30","pubTimestamp":1790688611,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nFWN45L0VW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CSL.AU","BK7508","BK7501","BK7511","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671126476","title":"CSL Partners With Amazon Web Services","url":"https://stock-news.laohu8.com/highlight/detail?id=2671126476","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671126476?lang=en_us&edition=fundamental","pubTime":"2026-09-29 10:15","pubTimestamp":1790648142,"startTime":"0","endTime":"0","summary":"CSL  partnered with Amazon Web Services to apply artificial intelligence and cloud technologies in advancing its biopharmaceutical research and clinical development, the biotechnology company said in a statement on Tuesday.The collaboration will enable scientists to connect and analyze data, identify targets sooner, accelerate timelines, and assess external opportunities efficiently, while fostering closer links between laboratory and computational work, the statement said.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2250418816.HKD","LU1868836591.USD","AMAA","LU0528227936.USD","BK4592","GB00BDT5M118.USD","LU2264538146.SGD","LU0310800379.SGD","IE000M9KFDE8.USD","LU0345770308.USD","LU0238689110.USD","LU2092937148.SGD","BK4554","LU2746668974.SGD","AMZZ","LU2471134879.HKD","LU0203201768.USD","LU1201861165.SGD","LU0980610538.SGD","LU0323591593.USD","BK4535","IE000MB6IJN5.SGD","IE00BJLML261.HKD","LU0353189763.USD","LU1074936037.SGD","LU0289960550.SGD","LU1066051811.HKD","BK7067","BK4551","LU1883839398.USD","LU2361044865.SGD","AMZP","LU1861127337.USD","IE0001KFT4U8.USD","LU1280957306.USD","SGXZ99366536.SGD","LU0820561909.HKD","LU2430703178.SGD","LU0210533765.USD","IE0034235303.USD","IE00B3SWFQ91.USD","HK0000304797.USD","LU2023250330.USD","LU0234572021.USD","LU1366192091.USD","LU0314104364.USD","LU1674673428.USD","LU0211328371.USD","BK4566","LU1435385759.SGD","IE00B19Z8X17.USD","LU0211327993.USD","LU2092627202.USD","LU2860962120.EUR","LU0048573561.USD","SG9999014914.USD","LU2417539215.USD","LU2552382132.HKD","LU0348723411.USD","LU2452424414.USD","LU2357305700.SGD","LU1691799644.USD","LU0345768153.USD","IE00BQXX3D17.EUR","LU1941712264.USD","IE0005OL40V9.USD","LU0708994859.HKD","LU1778281490.HKD","IE00B19Z8W00.USD","LU0256863811.USD","LU0061474705.USD","LU1718418525.SGD","LU1066053197.SGD","LU1935043536.SGD","IE000SO60NU8.SGD","LU0310799852.SGD","IE00BFSS8Q28.SGD","LU1839511570.USD","LU0133085943.USD","IE0004445015.USD","LU1316542783.SGD","IE00BK4W5L77.USD","SG9999002224.SGD","LU0823434583.USD","LU2420271590.USD","LU1868837136.USD","AMZD","LU0215105999.USD","LU2023251221.USD","SG9999004303.SGD","LU1861558580.USD","LU2236285917.USD","LU1934455277.USD","AZYY","LU1116320737.USD","SGXZ81514606.USD","LU2756315664.SGD","LU1548497426.USD","LU0170899867.USD","LU0130103400.USD","LU2896262040.SGD","SG9999014906.USD","BK4581","LU0648000940.SGD","IE0000B7K699.USD","LU2381873111.SGD","LU0130102774.USD","HULL","LU1941712348.USD","LU2237957902.USD","LU1084165304.USD","LU0251142724.SGD","IE00BKVL7J92.USD","LU0080751232.USD","LU1791710582.SGD","IE00BKDWB100.SGD","LU2592432038.USD","LU0943347566.SGD","LU1235294995.USD","SG9999018865.SGD","LU2111349929.HKD","LU0965509010.AUD","LU2211815571.USD","LU0096362180.USD","LU1551013342.USD","LU0689472784.USD","IE00BFXG0V08.USD","LU2242649171.HKD","BK4559","LU0784383803.USD","IE00BFSS7M15.SGD","LU1496350502.SGD","ONLN","LU1861559042.SGD","IE0004445239.USD","BK4612","LU1633808545.USD","LU0354030511.USD","SG9999018857.SGD","BK4527","LU0109391861.USD","LU2552382215.SGD","LU0708995401.HKD","IE000ITXATA3.USD","BK4533","LU1066051225.USD","BK4561","LU1037948897.HKD","LU0494093205.USD","LU1674673691.USD","LU0198837287.USD","LU0265550946.USD","LU0308772762.SGD","LU2065170008.USD","LU1366333091.USD","LU2362540622.SGD","IE0004091025.USD","LU0345769631.USD","SG9999002232.USD","LU2125154935.USD","LU2602419157.SGD","LU0719512351.SGD","LU0820561818.USD","LU1935043023.USD","LU2168564222.USD","LU0640476718.USD","LU2487616109.SGD","LU0053666078.USD","LU1868837300.USD","LU2764263039.SGD","LU0061474960.USD","LU0861579265.USD","LU2463028550.USD","IE00B5TLWC47.USD","IE00B4JS1V06.HKD","IE00B7KXQ091.USD","IE00BJJMRY28.SGD","LU0724617625.USD","LU0072461881.USD","LU0154236417.USD","LU0949170426.SGD","BK4604","LU2505996681.GBP","LU0742534661.SGD","LU2211817866.USD","LU2764263203.CNY","LU0079474960.USD","LU1629891620.HKD","LU0070217475.USD","LU0251131958.USD","LU1989764664.SGD","LU2242650005.HKD","LU0128525929.USD","LU1720051108.HKD","LU0683600562.USD","LU1989764748.USD","IE000WAW04H5.SGD","LU1935042991.SGD","WANT","LU1244550494.USD","LU2087621335.USD","IE00BZ1G4Q59.USD","LU0289941410.SGD","LU1267930730.SGD","LU2168564149.EUR","LU0256863902.USD","LU2750360997.AUD","LU2361044949.HKD","SG9999014898.SGD","IE0002270589.USD","IE0009G5SDU7.USD","LU2237438978.USD","IE0003U64NQ7.SGD","LU2089283258.USD","AMZN","LU1145028129.USD","LU1914381329.SGD","IE00B7SZLL34.SGD","LU0345774391.USD","LU1267930490.SGD","BK4543","IE00BQXX3F31.USD","LU0345768740.USD","IE00B19Z9505.USD","LU0302445910.USD","LU2108987350.USD","LU2065171311.SGD","LU2168563687.JPY","LU2023250504.SGD","LU2362541273.HKD","BK4122","LU1815333072.USD","IE00BKPKM429.USD","LU2054465674.USD","LU0784385840.USD","BK4532","AMZU","IE00B19Z3581.USD","LU1069344957.HKD","LU2065169927.USD","BK4524","LU2746668461.USD","LU2360106780.USD","HK0000914686.HKD","LU0871640123.AUD","LU0175139822.USD","LU1988902786.USD","LU2168564065.EUR","IE00BN29S564.USD","SGXZ23171101.USD","SG9999000418.SGD","IE00BK4W5M84.HKD","LU2456880835.USD","LU0143551892.USD","LU2317271919.USD","LU0056508442.USD","IE000BZT7R73.USD","USAW.SI","LU0208291251.USD","LU0889565833.HKD","BK4503","HK0000914660.USD","LU1119994496.HKD","LU0788109477.HKD","LU0820562030.AUD","LU1301847155.USD","LU0784385170.HKD","LU0265550359.USD","LU0011850046.USD","LU1823568750.SGD","LU0162691827.USD","LU1880398554.USD","SGXZ31699556.SGD","LU2213496289.HKD","LU2999663052.SGD","SG9999015945.SGD","IE00BMPRXN33.USD","LU1232071149.USD","LU0109392836.USD","LU2403377893.USD","IE000KEQY171.SGD","RTH","BK4585","LU1934455194.USD","LU2077746001.SGD","LU2125154778.USD","IE00B19Z3B42.SGD","OGIG","IE00BJTD4N35.SGD","LU1429558221.USD","LU0345774631.USD","LU1127390331.HKD","IE00B5949003.HKD","IE00BWXC8680.SGD","LU1323610961.USD","SG9999014880.SGD","LU2720916845.USD","BK4588","LU2764262908.HKD","LU2087625088.SGD","ILDR","BK4548","LU1116320901.HKD","LU0985320562.USD","LU1935043452.HKD","BK4507","LU1035775433.USD","LU2756315318.SGD","BK4598","IE00B4YYXB79.USD","LU2543165471.USD","LU0157215616.USD","LU1496350171.SGD","LU0234570918.USD","LU0390134368.USD","LU2471134796.USD","BK4596","LU2430703251.USD","IE00BJTD4V19.USD","IE00BMPRXR70.SGD","LU0107464264.USD","LU2023250843.SGD","CSL.AU","LU1244550577.SGD","LU2505996509.AUD","LU0823434740.USD","SG9999015952.SGD","IE00BQXX3C00.GBP","LU0138981039.USD","SGXZ80539844.SGD","IE00B1BXHZ80.USD","SG9999017495.SGD","LU2247934214.USD","LU2461242641.AUD","LU1880398471.USD","LU0466842654.USD","BK4550","LU1046421795.USD","LU1852331112.SGD","LU0158827948.USD","LU2028103732.USD","LU2361045086.USD","LU0345769128.USD","LU2083900584.USD","LU0823421416.USD","SAMZNmain","LU0965509101.SGD","IE00BMPRXQ63.HKD","LU2462157665.USD","LU1201861249.SGD","LU2430703095.HKD","LU0061475181.USD","BK4538","LU0648001328.SGD","LU2089284900.SGD","HK0000532082.HKD","LU1064131342.USD","LU0210536198.USD","LU1934455863.HKD","IE00BJJMRX11.SGD","IE000YTNTUN2.SGD","BK4220","LU1066051498.USD","IE0004086264.USD","LU0077335932.USD","LU1244550221.USD","BK4579","LU0823411888.USD","LU1720051017.SGD","BK7511","LU2750360641.GBP","LU2462591277.SGD","LU0127658192.USD","LU0456855351.SGD","SG9999015986.USD","LU1814569148.SGD","LU2106854487.HKD","SGXZ51526630.SGD","LU2063271972.USD","IE00B775H168.HKD","LU2471134523.USD","LU1551013425.SGD","LU1267930573.SGD","LU0320765059.SGD","LU2237957811.SGD","LU0642271901.SGD","IE00B775SV38.USD","IE00BYQQ9H92.USD","LU1037948541.HKD","LU0203202063.USD","LU0072462426.USD","LU1868836757.USD","LU0353189680.USD","IE0009356076.USD","LU1979441026.SGD","LU0251132253.USD","LU0957791311.USD","LU2360032135.SGD","LU0276348264.USD","LU2462591350.SGD","LU0174119429.USD","SG9999001077.SGD","LU1153585028.USD","LU1917777945.USD","BK4534","AMZO","LU0149725797.USD","LU2265009873.SGD","LU2552382058.USD","LU2168564495.EUR","IE000F7OJYX1.SGD","LU0417517546.SGD","LU0784384876.USD","LU0096364046.USD","LU2097829019.USD","LU0965509283.SGD","BK7501","LU1935042488.USD","IE000W1ABFV2.USD","LU0029864427.USD","LU0345770993.USD","LU2471134952.CNY","HK0000304805.HKD","SGXZ44715902.SGD","LU0823421333.USD","LU0048584097.USD","LU0965508806.USD","LU2065171402.SGD","LU0082616367.USD","LU0316494557.USD","LU1791710400.SGD","LU0312595415.SGD","IE00B1XK9C88.USD","LU0158827781.USD","LU2271345857.HKD","AMZW","LU0320765489.SGD","CLIX","LU2637965513.SGD","LU1803068979.SGD","LU0787776722.HKD","LU0267386448.USD","LU0070302665.USD","LU2326559502.SGD","SG9999015978.USD","LU1804176565.USD","LU0882574139.USD","LU1974910355.USD","BK7508","LU2362541513.USD","AMZG","LU0672654240.SGD","LU2954938101.SGD","LU0097036916.USD","LU1868836914.USD","LU2275660780.HKD","LU0342679015.USD","IE00B3S45H60.SGD","LU1261432733.SGD","LU1935042215.USD","LU0210528500.USD","LU0354030438.USD","LU0786609619.USD","LU0964807845.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671264546","title":"CSL Ltd and AWS Collaborate to Advance Biopharmaceutical Research and Development","url":"https://stock-news.laohu8.com/highlight/detail?id=2671264546","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671264546?lang=en_us&edition=fundamental","pubTime":"2026-09-29 09:58","pubTimestamp":1790647118,"startTime":"0","endTime":"0","summary":"Sept 29 (Reuters) - CSL Limited::*CSL AND AWS COLLABORATE TO ADVANCE BIOPHARMACEUTICAL RESEARCH AND DEVELOPMENT*COLLABORATION WITH AWS TO APPLY ARTIFICIAL INTELLIGENCE AND CLOUD TECHNOLOGIES TO SUPPOR","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nRSD9wgM5F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","BK7501","BK7508","BK7511","CSL.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671261940","title":"Neuren Says US Patent Allowance Could Extend Trofinetide Protection to 2041","url":"https://stock-news.laohu8.com/highlight/detail?id=2671261940","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671261940?lang=en_us&edition=fundamental","pubTime":"2026-09-29 09:25","pubTimestamp":1790645148,"startTime":"0","endTime":"0","summary":"Neuren Pharmaceuticals  said partner Acadia Pharmaceuticals received a notice of allowance from the US Patent and Trademark Office for a new US patent covering weight-banded dosing of trofinetide, according to a Tuesday Australian bourse filing.The patent, once issued and with six months of pediatric exclusivity, is expected to extend US patent protection for trofinetide to March 28, 2041, nearly five years beyond the current protection period, the filing said.Trofinetide is marketed in the US under the brand names Daybue and Daybue Stix for patients aged two years and older with Rett syndrome, the filing added.The company's shares rose 2% in recent Tuesday trade.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7096","USRD","BK7508","NEU.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671226543","title":"CSL Partners with AWS to Apply AI, Cloud Tools in Biopharma R&D","url":"https://stock-news.laohu8.com/highlight/detail?id=2671226543","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671226543?lang=en_us&edition=fundamental","pubTime":"2026-09-29 07:47","pubTimestamp":1790639236,"startTime":"0","endTime":"0","summary":"CSL partners with AWS to apply AI, cloud tools in biopharma R&DCSL entered a collaboration with AWS to apply AI and cloud tools across research and clinical development.Partnership targets faster targ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nNDL47WYMf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000914686.HKD","IE00BQXX3D17.EUR","LU0097036916.USD","LU0265550946.USD","LU2265009873.SGD","LU2746668974.SGD","IE0009356076.USD","LU0029864427.USD","LU0784385170.HKD","IE0009G5SDU7.USD","LU2023250330.USD","LU1935043452.HKD","LU2362541273.HKD","LU0390134368.USD","IE00BJLML261.HKD","LU0061475181.USD","LU1201861165.SGD","LU2211817866.USD","IE00BQXX3F31.USD","LU0648000940.SGD","LU1323610961.USD","LU0251131958.USD","LU2023251221.USD","LU0342679015.USD","IE00B19Z3B42.SGD","LU0957791311.USD","BK7501","LU1084165304.USD","LU2065171402.SGD","LU0256863902.USD","LU1261432733.SGD","IE0004445015.USD","LU2543165471.USD","WANT","LU1815333072.USD","LU2487616109.SGD","LU1814569148.SGD","AZYY","IE00BFSS7M15.SGD","LU2023250504.SGD","LU2403377893.USD","LU0345768153.USD","LU1069344957.HKD","LU0070217475.USD","LU1883839398.USD","LU2361044865.SGD","LU2750360997.AUD","IE00BYQQ9H92.USD","LU0964807845.USD","LU2242650005.HKD","LU0133085943.USD","BK4550","LU0082616367.USD","IE00BZ1G4Q59.USD","LU2602419157.SGD","IE00B1BXHZ80.USD","LU0289941410.SGD","LU0256863811.USD","LU2097829019.USD","LU2463028550.USD","LU0466842654.USD","SAMZNmain","IE000YTNTUN2.SGD","LU2430703251.USD","LU2362541513.USD","LU0784385840.USD","LU2896262040.SGD","LU1267930490.SGD","LU0314104364.USD","LU0456855351.SGD","LU1551013342.USD","BK4598","LU0742534661.SGD","LU1066053197.SGD","LU1861558580.USD","IE00BJJMRX11.SGD","BK4579","LU0238689110.USD","LU2271345857.HKD","LU2065169927.USD","LU0302445910.USD","BK7511","IE00B4JS1V06.HKD","LU0234570918.USD","LU0345769128.USD","SG9999018865.SGD","LU2471134952.CNY","LU0672654240.SGD","IE00BFSS8Q28.SGD","LU2211815571.USD","IE00BJTD4N35.SGD","BK4596","SGXZ99366536.SGD","BK4220","SG9999014898.SGD","IE000F7OJYX1.SGD","LU1064131342.USD","LU2168564222.USD","LU2065170008.USD","BK4524","SG9999004303.SGD","LU2357305700.SGD","LU0820561909.HKD","BK4581","LU1988902786.USD","IE0003U64NQ7.SGD","LU1046421795.USD","LU0648001328.SGD","LU2168564065.EUR","LU1674673428.USD","LU0079474960.USD","LU1267930730.SGD","SG9999015978.USD","LU0353189763.USD","LU1880398471.USD","LU0215105999.USD","LU1244550577.SGD","LU1979441026.SGD","LU0149725797.USD","RTH","AMZN","LU0154236417.USD","CLIX","ILDR","LU1917777945.USD","SGXZ81514606.USD","LU0198837287.USD","LU0162691827.USD","LU2505996681.GBP","LU0267386448.USD","LU1037948541.HKD","LU0316494557.USD","LU1791710400.SGD","LU0096364046.USD","LU1935043023.USD","LU0323591593.USD","BK4566","LU0642271901.SGD","LU0107464264.USD","LU0096362180.USD","LU2168564149.EUR","LU0138981039.USD","LU1934455194.USD","LU2471134523.USD","IE000SO60NU8.SGD","IE000KEQY171.SGD","LU1496350171.SGD","LU0158827781.USD","LU1201861249.SGD","BK7067","SG9999015945.SGD","LU1035775433.USD","LU1496350502.SGD","IE00B7KXQ091.USD","LU1720051108.HKD","LU2317271919.USD","LU1804176565.USD","IE000ITXATA3.USD","LU2552382215.SGD","LU0708994859.HKD","LU0965509101.SGD","LU0784383803.USD","IE0002270589.USD","LU1935042991.SGD","LU2860962120.EUR","BK4551","IE00B19Z3581.USD","LU2360032135.SGD","LU1429558221.USD","BK4612","IE0004086264.USD","LU0072461881.USD","IE00BMPRXR70.SGD","LU1868837300.USD","LU0070302665.USD","LU2125154778.USD","IE0001KFT4U8.USD","LU0203202063.USD","LU0211328371.USD","LU1914381329.SGD","LU0784384876.USD","AMZW","LU0683600562.USD","LU1066051498.USD","IE00BKDWB100.SGD","SG9999002232.USD","LU2237957811.SGD","LU2092627202.USD","LU0143551892.USD","LU0354030438.USD","LU2462591277.SGD","SGXZ44715902.SGD","LU2360106780.USD","LU2756315664.SGD","LU0949170426.SGD","LU2125154935.USD","LU0708995401.HKD","LU2326559502.SGD","LU0251132253.USD","BK4559","LU2552382132.HKD","LU1934455277.USD","LU2471134796.USD","BK4122","LU1868836757.USD","LU1301847155.USD","LU0308772762.SGD","LU2471134879.HKD","LU2999663052.SGD","HK0000914660.USD","IE00BKVL7J92.USD","HK0000304805.HKD","LU0203201768.USD","AMZP","BK4548","LU2462157665.USD","LU2108987350.USD","LU1551013425.SGD","IE00BK4W5L77.USD","LU2247934214.USD","LU0823411888.USD","LU2077746001.SGD","LU0320765489.SGD","LU0417517546.SGD","LU0787776722.HKD","LU0130103400.USD","LU1629891620.HKD","LU2462591350.SGD","IE00B7SZLL34.SGD","LU1880398554.USD","LU0985320562.USD","IE00B3S45H60.SGD","AMZG","IE0034235303.USD","LU2750360641.GBP","LU2381873111.SGD","LU1718418525.SGD","IE000BZT7R73.USD","LU0312595415.SGD","LU1868836914.USD","LU0061474960.USD","LU0965508806.USD","BK4534","LU2089284900.SGD","LU0354030511.USD","LU1066051225.USD","LU0048584097.USD","IE00BMPRXQ63.HKD","LU0011850046.USD","LU0823434583.USD","LU2237957902.USD","LU2362540622.SGD","LU1232071149.USD","LU2452424414.USD","LU1116320737.USD","SGXZ23171101.USD","LU2092937148.SGD","OGIG","LU1235294995.USD","LU0175139822.USD","IE0004445239.USD","LU1868836591.USD","LU2275660780.HKD","LU0494093205.USD","LU2106854487.HKD","LU1941712348.USD","LU0528227936.USD","LU0889565833.HKD","BK7508","SG9999015986.USD","BK4507","LU0345768740.USD","LU0820562030.AUD","LU1633808545.USD","LU1935042215.USD","LU2087625088.SGD","LU2250418816.HKD","LU1861559042.SGD","LU2361045086.USD","IE000MB6IJN5.SGD","LU2213496289.HKD","IE00BJJMRY28.SGD","AMZD","LU0965509010.AUD","SG9999014914.USD","LU0689472784.USD","LU2063271972.USD","LU0345770308.USD","LU2237438978.USD","AMZO","BK4561","LU0174119429.USD","LU0265550359.USD","IE00BK4W5M84.HKD","LU1116320901.HKD","LU2168564495.EUR","AMZY","LU1674673691.USD","LU0345774631.USD","AMAA","IE00B19Z8W00.USD","LU2083900584.USD","AMZU","LU0251142724.SGD","LU1280957306.USD","SGXZ80539844.SGD","LU2764262908.HKD","LU0158827948.USD","LU1066051811.HKD","LU0823434740.USD","SG9999000418.SGD","IE00BMPRXN33.USD","HK0000532082.HKD","LU0345769631.USD","LU1037948897.HKD","LU1791710582.SGD","LU2720916845.USD","IE0000B7K699.USD","IE00B4YYXB79.USD","LU0823421416.USD","IE00B19Z9505.USD","LU1778281490.HKD","IE00BWXC8680.SGD","LU0289960550.SGD","LU1989764664.SGD","LU0128525929.USD","LU1861127337.USD","LU2764263203.CNY","LU0965509283.SGD","IE000M9KFDE8.USD","BK4604","BK4538","IE00B5949003.HKD","CSL.AU","LU1435385759.SGD","LU1934455863.HKD","LU0109392836.USD","LU2168563687.JPY","LU1868837136.USD","USAW.SI","SG9999015952.SGD","IE00B5TLWC47.USD","LU0640476718.USD","IE000WAW04H5.SGD","LU1366192091.USD","BK4535","LU0276348264.USD","LU0048573561.USD","LU0210533765.USD","LU0170899867.USD","LU0345774391.USD","LU1119994496.HKD","LU1823568750.SGD","LU1852331112.SGD","LU2954938101.SGD","LU1366333091.USD","LU2461242641.AUD","LU0210536198.USD","LU2420271590.USD","SGXZ31699556.SGD","BK4585","LU0211327993.USD","SG9999018857.SGD","LU1074936037.SGD","SG9999017495.SGD","BK4532","LU2746668461.USD","BK4592","LU1145028129.USD","LU1316542783.SGD","LU1244550221.USD","BK4533","LU2430703095.HKD","LU0310799852.SGD","AMZZ","LU0823421333.USD","LU1548497426.USD","IE0005OL40V9.USD","LU0788109477.HKD","LU0072462426.USD","LU0077335932.USD","LU0210528500.USD","LU2087621335.USD","LU2552382058.USD","LU2756315318.SGD","LU2430703178.SGD","ONLN","LU2361044949.HKD","LU1989764748.USD","LU0345770993.USD","LU2023250843.SGD","LU1941712264.USD","LU2065171311.SGD","LU2592432038.USD","LU2089283258.USD","LU0320765059.SGD","LU1974910355.USD","LU2054465674.USD","LU0208291251.USD","IE00B775SV38.USD","LU0056508442.USD","LU2637965513.SGD","IE00B1XK9C88.USD","SGXZ51526630.SGD","GB00BDT5M118.USD","BK4503","IE000W1ABFV2.USD","BK4527","LU1244550494.USD","LU0157215616.USD","IE00B19Z8X17.USD","BK4543","LU1839511570.USD","BK4554","LU2111349929.HKD","LU2417539215.USD","LU2456880835.USD","LU1935043536.SGD","LU0871640123.AUD","SG9999001077.SGD","LU2236285917.USD","BK4588","LU1935042488.USD","LU0130102774.USD","LU0861579265.USD","LU0310800379.SGD","SG9999014880.SGD","LU1803068979.SGD","LU1720051017.SGD","HK0000304797.USD","LU0234572021.USD","HULL","IE00BFXG0V08.USD","LU2242649171.HKD","LU2028103732.USD","LU1153585028.USD","LU0080751232.USD","LU0353189680.USD","SG9999014906.USD","IE00B3SWFQ91.USD","SG9999002224.SGD","LU0943347566.SGD","LU0348723411.USD","IE00BJTD4V19.USD","LU2505996509.AUD","LU0053666078.USD","IE00BN29S564.USD","LU0882574139.USD","LU1127390331.HKD","LU0719512351.SGD","LU0109391861.USD","IE00BKPKM429.USD","LU0820561818.USD","LU2764263039.SGD","LU1267930573.SGD","IE0004091025.USD","IE00BQXX3C00.GBP","LU0980610538.SGD","LU0127658192.USD","LU2264538146.SGD","IE00B775H168.HKD","LU0724617625.USD","LU0786609619.USD","LU0061474705.USD","LU1691799644.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671626514","title":"CSL Ltd - Collaboration with Amazon Web Services","url":"https://stock-news.laohu8.com/highlight/detail?id=2671626514","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671626514?lang=en_us&edition=fundamental","pubTime":"2026-09-29 07:44","pubTimestamp":1790639070,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nFWN45K0GN:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","CSL.AU","BK7511","BK7501","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671482265","title":"In Clinical Development, CSL Working with AWS to Reduce Manual Effort in Areas Including Protocol Authoring, Others","url":"https://stock-news.laohu8.com/highlight/detail?id=2671482265","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671482265?lang=en_us&edition=fundamental","pubTime":"2026-09-29 07:44","pubTimestamp":1790639070,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nFWN45K0GN:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CSL.AU","BK7508","BK7501","BK7511","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671265151","title":"CSL Ltd - CSL and AWS Collaborate to Advance Biopharmaceutical R&D","url":"https://stock-news.laohu8.com/highlight/detail?id=2671265151","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671265151?lang=en_us&edition=fundamental","pubTime":"2026-09-29 07:44","pubTimestamp":1790639070,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nFWN45K0GN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CSL.AU","BK7067","BK7501","BK7508","BK7511"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671145265","title":"CSL Ltd - Collaboration with AWS to Apply Artificial Intelligence and Cloud Technologies to Support Co's Research & Clinical Development","url":"https://stock-news.laohu8.com/highlight/detail?id=2671145265","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671145265?lang=en_us&edition=fundamental","pubTime":"2026-09-29 07:44","pubTimestamp":1790639070,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nFWN45K0GN:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CSL.AU","BK7511","BK7508","BK7067","BK7501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670631402","title":"Mayne Pharma to Pay $650,000 to Settle US Generic Drug Claims","url":"https://stock-news.laohu8.com/highlight/detail?id=2670631402","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670631402?lang=en_us&edition=fundamental","pubTime":"2026-09-28 08:15","pubTimestamp":1790554551,"startTime":"0","endTime":"0","summary":"Mayne Pharma Group  has agreed to pay $650,000 to resolve civil claims brought by attorneys general from 49 US states and territories as part of a broader investigation into the generic pharmaceutical industry, according to a Monday Australian bourse filing.The settlement, which does not involve any admission of liability or wrongdoing, aims to avoid further legal expenses, management distraction, and uncertainty, per the filing.The company said the settlement requires only limited administrative measures, including maintaining its existing antitrust compliance policy and issuing annual compliance notices for two years, without imposing any restrictions on its business operations.The settlement remains subject to final court approval, the filing added.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7508","BK7096","MYX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670747404","title":"Mayne Pharma Group - Settlement Made Without Admission of Liability or Wrongdoing by Mayne Pharma","url":"https://stock-news.laohu8.com/highlight/detail?id=2670747404","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670747404?lang=en_us&edition=fundamental","pubTime":"2026-09-28 07:45","pubTimestamp":1790552739,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260927:nFWN45I00I:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MYX.AU","BK7096","BK7508"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":4,"totalSize":92,"code":"91000000","status":"200"}]}}